NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers (GCCs)? Cactus Life Sciences at the NASSCOM GCC Summit 2025

The theme for this year’s NASSCOM GCC Summit, “The Next GCC Frontier: Ambition, Agility, Ascent,” couldn’t have been more apt. Held in Hyderabad on April 22–23, 2025, the event brought together visionary leaders, strategists, technologists, and innovators to examine the evolving role of India’s global capability centers (GCCs) and their journey from execution engines to…...
Read More

Top Stories

“Voice of Patient” in Publications: Trends and

This page contains a poster presented at the 21st Annual...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical Affairs

This whitepaper explores the role of social media in enhancing Medical Affairs functions. As digital...
Health Literacy

Health Literacy – Cactus Life Sciences Leads the Way

It’s our responsibility as an industry to emphasize the importance of health literacy and help...

Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible

Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...
Patient Inclusivity Survey - PM360 and Cactus Life Sciences

Patient Inclusivity Survey

How many life sciences companies are actually making an effort to include patients in things...
Why the Healthcare Industry MUST Care About the Caregiver

Why the Healthcare Industry MUST Care About the Caregiver

Caregivers are vital in the treatment of a patient, whether at home or in a...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.